Fexofenadine hydrochloride 180 MG Oral Tablet [Wal-Fex] — RxCUI 1116528
RxNorm drug concept · Semantic branded drug
RxCUI 1116528
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
10 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1116528
Official nameFexofenadine hydrochloride 180 MG Oral Tablet [Wal-Fex]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asWal-Fex 24 HR 180 MG Oral Tablet; Wal-Fex Allergy 180 MG 24HR Oral Tablet
FDA products mapped1
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fexofenadine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Fexofenadine is an antihistamine that relieves common allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and an itchy nose or throat caused by hay fever o...
- The FDA labels for fexofenadine do not list drowsiness as a side effect in the consumer sections provided. That said, everyone responds a little differently, so pay attention to ho...
- You'll want to be careful here. The label says not to take fexofenadine at the same time as aluminum or magnesium antacids — the kind used for heartburn or upset stomach — and to a...
- Can I take fexofenadine with my antacids or a glass of orange juice?
🕸️ Concept Web — How Fexofenadine hydrochloride 180 MG Oral Tablet [W... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fexofenadine hydrochloride 180 MG Oral Tablet [Wal-Fex]
RxCUI 1116528 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Fexofenadine
87636IN -
Fexofenadine hydrochloride
236474PIN
-
Fexofenadine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Wal-Fex
1116525BN
-
Wal-Fex
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fexofenadine Oral Tablet
372196SCDF -
Fexofenadine hydrochloride Oral Tablet
2646135SCDFP -
Fexofenadine Oral Product
1165011SCDG -
Fexofenadine Pill
1165012SCDG -
Fexofenadine hydrochloride Oral Product
2662915SCDGP -
Fexofenadine hydrochloride Pill
2659122SCDGP -
Fexofenadine Oral Tablet [Wal-Fex]
1116527SBDF -
Fexofenadine hydrochloride Oral Tablet [Wal-Fex]
2655080SBDFP - +5 more in this family
-
Fexofenadine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fexofenadine hydrochloride 180 MG Oral Tablet
997420SCD -
Fexofenadine hydrochloride 180 MG
997413SCDC -
Fexofenadine hydrochloride 180 MG [Wal-Fex]
1116526SBDC
-
Fexofenadine hydrochloride 180 MG Oral Tablet
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fexofenadine hydrochloride 180 MG Oral Tablet
SCD · 997420 -
Fexofenadine hydrochloride 180 MG
SCDC · 997413 -
Fexofenadine Oral Tablet
SCDF · 372196 -
Fexofenadine hydrochloride Oral Tablet
SCDFP · 2646135 -
Fexofenadine Oral Product
SCDG · 1165011 -
Fexofenadine Pill
SCDG · 1165012 -
Fexofenadine hydrochloride Oral Product
SCDGP · 2662915 -
Fexofenadine hydrochloride Pill
SCDGP · 2659122
Brand-Name Concepts
-
Fexofenadine hydrochloride 180 MG [Wal-Fex]
SBDC · 1116526 -
Fexofenadine Oral Tablet [Wal-Fex]
SBDF · 1116527 -
Fexofenadine hydrochloride Oral Tablet [Wal-Fex]
SBDFP · 2655080 -
Wal-Fex Oral Product
SBDG · 1187623 -
Wal-Fex Pill
SBDG · 1187624 -
Wal-Fex
BN · 1116525
📦 FDA Products & Package NDCs
1 product · 10 package NDCs
10 package NDCs map to RxCUI 1116528 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-0784-07 | 1 BLISTER PACK in 1 CARTON (0363-0784-07) / 5 TABLET in 1 B... | Wal-Fex | Walgreens Company | 2011-04-13 |
| 00363-0784-15 | 1 BOTTLE in 1 CARTON (0363-0784-15) / 150 TABLET in 1 BOTTL... | Wal-Fex | Walgreens Company | 2011-04-13 |
| 00363-0784-18 | 180 TABLET in 1 BOTTLE (0363-0784-18) | Wal-Fex | Walgreens Company | 2022-07-13 |
| 00363-0784-29 | 3 BLISTER PACK in 1 CARTON (0363-0784-29) / 5 TABLET in 1 B... | Wal-Fex | Walgreens Company | 2011-04-13 |
| 00363-0784-30 | 1 BOTTLE in 1 CARTON (0363-0784-30) / 30 TABLET in 1 BOTTLE | Wal-Fex | Walgreens Company | 2011-04-13 |
| 00363-0784-40 | 1 BOTTLE in 1 CARTON (0363-0784-40) / 40 TABLET in 1 BOTTLE | Wal-Fex | Walgreens Company | 2011-04-13 |
| 00363-0784-43 | 2 BOTTLE in 1 CARTON (0363-0784-43) / 30 TABLET in 1 BOTTLE | Wal-Fex | Walgreens Company | 2011-04-13 |
| 00363-0784-45 | 1 BOTTLE in 1 CARTON (0363-0784-45) / 45 TABLET in 1 BOTTLE | Wal-Fex | Walgreens Company | 2011-04-13 |
| 00363-0784-75 | 1 BOTTLE in 1 CARTON (0363-0784-75) / 70 TABLET in 1 BOTTLE | Wal-Fex | Walgreens Company | 2011-04-13 |
| 00363-0784-90 | 1 BOTTLE in 1 CARTON (0363-0784-90) / 90 TABLET in 1 BOTTLE | Wal-Fex | Walgreens Company | 2011-04-13 |
Observed labelers:
Walgreens Company (10)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.